Cargando…
Advances in the study of subclinical AKI biomarkers
Acute kidney injury (AKI) is a prevalent and serious illness in all clinical departments, with a high morbidity and death rate, particularly in intensive care units, where prevention and treatment are crucial. As a result, active prevention, early detection, and timely intervention for acute kidney...
Autores principales: | Zou, Chenchen, Wang, Chentong, Lu, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449362/ https://www.ncbi.nlm.nih.gov/pubmed/36091391 http://dx.doi.org/10.3389/fphys.2022.960059 |
Ejemplares similares
-
Subclinical AKI is still AKI
por: Ronco, Claudio, et al.
Publicado: (2012) -
The potential roles of galectin-3 in AKI and CKD
por: Wang, Fengyun, et al.
Publicado: (2023) -
Ischemic Duration and Frequency Determines AKI-to-CKD Progression Monitored by Dynamic Changes of Tubular Biomarkers in IRI Mice
por: Dong, Yang, et al.
Publicado: (2019) -
OxInflammation: From Subclinical Condition to Pathological Biomarker
por: Valacchi, Giuseppe, et al.
Publicado: (2018) -
Nicotinamide Mononucleotide Attenuates Renal Interstitial Fibrosis After AKI by Suppressing Tubular DNA Damage and Senescence
por: Jia, Yan, et al.
Publicado: (2021)